+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID05880797

Study to Understand Oropharyngeal Carcinoma with or without HPV by Collecting Blood Samples Before and After Treatment

Led by Stanford University · Updated on 2026-04-13

1000

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What this Trial Is About

Researchers are studying the natural progression of oropharyngeal carcinoma OPC, including cases linked to the human papilloma virus HPV. The study aims to gather detailed information about the disease by collecting biological samples from patients diagnosed with OPC or related cancers that may originate in the oropharynx. Participants will have blood samples collected before starting treatment and at six additional times afterward. Tumor samples will also be collected on the first day of treatment. The study is observational, meaning it does not involve any experimental treatments but focuses on understanding the disease through sample collection. During the study, participants will provide blood samples prior to treatment and for up to 36 months following surgery. Researchers will analyze these samples to better understand OPC and HPV-related cancers. Participants involvement includes regular sample collections and medical evaluations, with careful monitoring throughout the study period, which spans multiple years.

CONDITIONS

Brief Title

Multidimensional and Multimodal Profiling of Oropharyngeal Carcinoma

Research Team

N

Nikita Bedi

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here